A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma
- Status
- WITHDRAWN
- Phase
- PHASE3
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)
- Status
- COMPLETED
- Phase
- PHASE3
Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients
- Status
- TERMINATED
- Phase
- PHASE1
Study of Thalidomide in Treatment of Advanced Nsclc (Dream-003)
- Status
- UNKNOWN
- Phase
- PHASE2
Tandem High Dose Chemotherapy With 131I-MIBG Treatment in High Risk Neuroblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Immunotherapy as Second-line in Patient With Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of [14 C]-Pevonedistat in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE2